X4 Pharmaceuticals Ownership | Who Owns X4 Pharmaceuticals?
X4 Pharmaceuticals Ownership Summary
X4 Pharmaceuticals is owned by 1.60% institutional investors, 2.30% insiders, and 96.10% retail investors. Bain capital life sciences investors is the largest institutional shareholder, holding 8.42% of XFOR shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.90% of its assets in X4 Pharmaceuticals shares.
XFOR Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | X4 Pharmaceuticals | 1.60% | 2.30% | 96.10% |
| Sector | Healthcare Stocks | 279.42% | 10.64% | -190.05% |
| Industry | Biotech Stocks | 64.05% | 10.69% | 25.27% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Bain capital life sciences investors | 16.92M | 8.42% | $12.41M |
| Nea management company | 14.99M | 7.46% | $10.99M |
| Blackrock funding, inc. /de | 11.06M | 5.51% | $8.11M |
| Blackrock | 10.68M | 5.34% | $6.19M |
| Vanguard group | 8.20M | 4.08% | $6.02M |
| Orbimed advisors | 7.13M | 3.55% | $5.23M |
| Kingdon capital management | 4.94M | 2.46% | $3.62M |
| Geode capital management | 3.50M | 1.74% | $2.57M |
| Axa | 3.07M | 1.53% | $2.25M |
| State street | 2.76M | 1.38% | $1.60M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Bain capital life sciences investors | 16.92M | 1.46% | $12.41M |
| Nea management company | 14.99M | 0.62% | $10.99M |
| Kingdon capital management | 4.94M | 0.52% | $3.62M |
| Pale fire capital se | 1.40M | 0.23% | $1.03M |
| Orbimed advisors | 7.13M | 0.11% | $5.23M |
| Ubs oconnor | 1.26M | 0.07% | $928.04K |
| Axa | 3.07M | 0.01% | $2.25M |
| Schonfeld strategic advisors | 1.39M | 0.01% | $1.02M |
| Cassady schiller wealth management | 20.00K | 0.01% | $14.67K |
| Bleichroeder lp | 17.86K | 0.00% | $13.11K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 10.68M | 0.00% | 1.94M |
| Susquehanna group, llp | 1.89M | 0.00% | 1.71M |
| Group one trading | 797.41K | 0.00% | 671.91K |
| Ubs group | 923.06K | 0.00% | 661.93K |
| Jpmorgan chase | 459.65K | - | 383.18K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Adage capital partners gp | - | - | -4.28M |
| Soleus capital management | - | - | -4.05M |
| Perceptive advisors | - | - | -3.55M |
| Avidity partners management lp | - | - | -2.41M |
| Sio capital management | - | - | -1.30M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Cantor fitzgerald, l. p. | 40.25K | 0.00% | 40.25K | $29.53K |
| Wolverine trading | 39.66K | - | 39.66K | $32.05K |
| Colony group | 25.02K | - | 25.02K | $18.36K |
| Ameriprise financial | 22.04K | - | 22.04K | $16.17K |
| Cibc world markets | 15.73K | 0.00% | 15.73K | $11.54K |
Sold Out
| Holder | Change |
|---|---|
| Frazier financial advisors | -10.00 |
| Headlands | -16.00 |
| Nelson, van denburg & campbell wealth management group | -22.00 |
| Eversource wealth advisors | -41.00 |
| Clearstead advisors | -100.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 96 | 1.05% | 98,519,817 | -1.31% | 1 | 0.06% | 42 | 10.53% | 24 | 9.09% |
| Dec 31, 2024 | 51 | -50.00% | 29,200,759 | -70.97% | 14 | 0.58% | 18 | -61.70% | 12 | -36.84% |
| Sep 30, 2024 | 102 | -2.86% | 100,589,648 | -0.93% | 50 | 1.94% | 47 | -16.07% | 19 | 5.56% |
| Jun 30, 2024 | 105 | 1.94% | 101,538,962 | -1.42% | 50 | 1.51% | 56 | 43.59% | 18 | -28.00% |
| Mar 31, 2024 | 103 | 7.29% | 103,000,336 | 6.45% | 57 | 2.40% | 39 | -13.33% | 25 | 31.58% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard US Total Market Shares ETF | 5.03M | 2.90% | 1.00 |
| Vanguard Total Stock Mkt Idx Inv | 159.10K | 2.22% | - |
| iShares Russell 2000 ETF | 84.03K | 1.17% | -14.31K |
| MEDICAL BioHealth EUR Acc | 1.78M | 1.06% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 64.53K | 0.90% | - |
| Fidelity Small Cap Index | 60.83K | 0.85% | 4.08K |
| State St Russell Sm/Mid Cp® Indx SL Cl I | 1.00M | 0.58% | - |
| State St Russell Sm/Mid Cp® Indx NL Cl C | 1.00M | 0.58% | - |
| Vanguard Russell 2000 ETF | 28.05K | 0.39% | -9.34K |
| UTM IM GBP AXA Framlington Biotech | 664.19K | 0.38% | -2.29M |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 16, 2025 | Baldry Mark | Chief Commercial Officer | Buy | $2.56K |
| May 17, 2024 | Baldry Mark | Chief Commercial Officer | Buy | $14.65K |
| Nov 15, 2024 | Baldry Mark | Chief Commercial Officer | Buy | $4.60K |
| Jan 24, 2025 | Ragan Paula | President and CEO | Sell | $34.72K |
| Jan 24, 2025 | Mostafa Adam S. | Chief Financial Officer | Sell | $33.95K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | 1 | - |
| 2025 Q1 | - | 5 |
| 2024 Q4 | 1 | 7 |
| 2024 Q3 | - | 1 |
| 2024 Q2 | - | - |
XFOR Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools